The US regulator has cleared TROP2-directed ADC datopotamab deruxtecan (Dato-DXd) under the Datroway trade name as a treatment for previously treated HR+/HER2- breast cancer, a few weeks after its ...

For the freshest news, join The Borneo Post's Telegram Channel and The Borneo Post on Newswav.

** THIS INFORMATION IS CORRECT AT TIME OF PUBLISHING. CHANGES MAY OCCUR WITHOUT PRIOR NOTICE. THE CINEMAS RESERVE THE RIGHT TO CANCEL ANY SHOW 30 – 60 MINUTES BEFORE THE SHOW STARTS. CHANGES SUCH AS ...